Climedo offers an integrated eCOA and EDC solution with hybrid capabilities for non-interventional studies and real-world evidence.
With its patient-centric approach and the continuous provision of data insights and visualizations on the current study progress, Climedo enables its customers to better communicate with healthcare professionals and other key opinion leaders (KOLs). This increases transparency, stimulates scientific dialog and accelerates the launch success of new medical innovations, reaching more patients faster.
Founded in Munich in 2017, Climedo is a leading partner for pharma, medtech, CROs and academic institutions with over 1.7 million patients enrolled.
